本页面由Tiger Trade Technology Pte. Ltd.提供服务

梯瓦制药

42.09
+0.62001.50%
盘后:42.210.1248+0.30%19:55 EDT
成交量:735.79万
成交额:3.09亿
市值:490.35亿
市盈率:70.15
高:42.59
开:41.17
低:41.17
收:41.47
52周最高:42.59
52周最低:19.98
股本:11.65亿
流通股本:10.87亿
量比:1.34
换手率:0.68%
股息:- -
股息率:- -
每股收益(TTM):0.6000
每股收益(LYR):1.21
净资产收益率:9.69%
总资产收益率:5.13%
市净率:6.32
市盈率(LYR):34.79

数据加载中...

2026/10/29

重要事件披露

Form 8-K - Current report
2026/09/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/16

重要事件披露

Form 8-K - Current report
2026/09/14

重要事件披露

Form 8-K - Current report
2026/09/14

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2026/09/11

重要事件披露

Form 8-K - Current report
2026/09/10

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/09/10

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/09/04

重要事件披露

Form 8-K - Current report
2026/09/04

重要事件披露

Form 8-K - Current report
2026/08/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/29

重要事件披露

Form 8-K - Current report
2026/06/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities